FindTrial
Sign In

COMP levels in Osteoarthritis

Cartilage Oligomeric Matrix Proteinase levels in Osteoarthritis of the Knee

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052253
Enrollment
90
Registered
2023-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

None listed

Sponsors

SIMFFER Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with Osteoarthritis of the knee. 2.Patients with radiological signs of Osteoarthritis. 3.Patients with pain and stiffness of the knee. 4.Ability to understand and the willingness to sign a written Informed Consent Form.

Exclusion criteria

Exclusion criteria: 1.Individuals who are not willing to participate in the study. 2.Patients who are undergoing emergency interventions. 3.Above 40 years of age.

Design outcomes

Primary

MeasureTime frame
The COMP levels of both the groups will be compared to test if the patients with Osteoarthritis of the knee have elevated levels.Timepoint: Baseline—

Countries

India

Contacts

Public ContactNachappa Sivanesan Uthraraj

SIMFFER Foundation

nash.s.uthraraj@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026